Alexandra Hanretty, PharmD*

For providers on the front lines, lessons learned can help inform strategies to enhance the protection of their health going forward.

Lefamulin, a recently approved pleuromutilin, adds to the current antibiotic armamentarium, although its place in therapy remains to be seen.